Loading insider details...
Beta
Latest Form 4 (Feb 23, 2026): Grant/Award of 815,000 CNTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 23, 2026 | Context Therapeutics Inc. (CNTX) | Grant/Award | 815,000 | n/a |
| Jun 10, 2025 | Context Therapeutics Inc. (CNTX) | Purchase | 100,000 | $70.1K |
| Feb 14, 2025 | Context Therapeutics Inc. (CNTX) | Grant/Award | 802,700 | n/a |
| Mar 22, 2024 | Context Therapeutics Inc. (CNTX) | Grant/Award | 291,402 | n/a |
| Feb 22, 2023 | Context Therapeutics Inc. (CNTX) | Purchase | 5,823 | $4.9K |
| Feb 14, 2023 | Context Therapeutics Inc. (CNTX) | Grant/Award | 287,544 | n/a |
| Feb 13, 2023 | Context Therapeutics Inc. (CNTX) | Purchase | 5,606 | $4.9K |
| Feb 6, 2023 | Context Therapeutics Inc. (CNTX) | Purchase | 5,040 | $4.9K |
| Jan 30, 2023 | Context Therapeutics Inc. (CNTX) | Purchase | 7,027 | $4.9K |
| Jan 23, 2023 | Context Therapeutics Inc. (CNTX) | Purchase | 6,839 | $4.9K |